Literature DB >> 19541949

Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brands.

Mark Parascandola1, Erik Augustson, Mary E O'Connell, Stephen Marcus.   

Abstract

INTRODUCTION: In recent years, there has been a proliferation of potential reduced-exposure tobacco products (PREPs) marketed that claim to be less harmful or less addictive, compared with conventional cigarettes. Tobacco control scientists have raised concerns about the potential adverse impact of marketing of these products for smoking prevention and cessation efforts. Although these products have not been widely used among smokers, there are few data available on consumers' awareness and attitudes toward these products.
METHODS: Data were obtained from the 2003 and 2005 Health Information National Trends Survey, a nationally representative telephone survey of adults 18 years and older regarding health communication and associated beliefs and behaviors. Our study population consisted of 6,369 respondents in 2003 and 5,586 respondents in 2005, of whom 19% were current smokers and 28% were former smokers.
RESULTS: In 2005, 45% of respondents had heard of at least one PREP product, while only 4.8% had actually tried one. Awareness and use were substantially higher among current smokers (55.6% and 12.7%). Awareness was highest for Marlboro Ultra Smooth (MUS) (30.2%), Eclipse (18.2%), Quest (7.8%), and Ariva (5.4%), while less than 2% for any other product. Of respondents who had tried a PREP, 50% cited harm reduction or assistance in quitting as a reason for trying the product and 30% believed that the product was less harmful than their usual brand. In the combined 2003 and 2005 dataset, 54.4% of current smokers stated that they would be "very" or "somewhat" interested in trying a cigarette advertised as less harmful, while only 3.2% of former smokers and 1.1% of never-smokers were interested. Among current smokers, interest was higher in females and non-Hispanic Whites, and among daily smokers, those who smoked 20 or more cigarettes per day and those who were not considering quitting. Smokers interested in PREPs were substantially more likely to rate their perceived lung cancer risk as high (40.3% vs. 8.3%) and to worry frequently about developing lung cancer (19.7% vs. 4%). DISCUSSION: These results suggest that there is a substantial level of interest among current smokers in cigarettes marketed with claims of reduced exposure or harm. Of particular concern is that "health conscious" smokers and heavy smokers not planning to quit may be especially vulnerable to PREP marketing messages and view such products as an alternative to smoking cessation.

Entities:  

Mesh:

Year:  2009        PMID: 19541949      PMCID: PMC2722238          DOI: 10.1093/ntr/ntp082

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  23 in total

1.  Clearing the smoke: the science base for tobacco harm reduction--executive summary.

Authors:  K Stratton; P Shetty; R Wallace; S Bondurant
Journal:  Tob Control       Date:  2001-06       Impact factor: 7.552

2.  Smoker and ex-smoker reactions to cigarettes claiming reduced risk.

Authors:  S Shiffman; J L Pillitteri; S L Burton; M E Di Marino
Journal:  Tob Control       Date:  2004-03       Impact factor: 7.552

3.  Preliminary investigation of the advertising and availability of PREPs, the new "safe" tobacco products.

Authors:  Norval Hickman; Elizabeth A Klonoff; Hope Landrine; Kennon Kashima; Bina Parekh; Senaida Fernandez; Kamala Thomas; Catherine Brouillard; Michele Zolezzi; Jennifer Jensen; Zorahna Weslowski
Journal:  J Behav Med       Date:  2004-08

4.  Smokers' misperceptions of light and ultra-light cigarettes may keep them smoking.

Authors:  L T Kozlowski; M E Goldberg; B A Yost; E L White; C T Sweeney; J L Pillitteri
Journal:  Am J Prev Med       Date:  1998-07       Impact factor: 5.043

5.  The Health Information National Trends Survey (HINTS): development, design, and dissemination.

Authors:  David E Nelson; Gary L Kreps; Bradford W Hesse; Robert T Croyle; Gordon Willis; Neeraj K Arora; Barbara K Rimer; K V Viswanath; Neil Weinstein; Sara Alden
Journal:  J Health Commun       Date:  2004 Sep-Oct

6.  Surveillance for selected tobacco-use behaviors--United States, 1900-1994.

Authors:  G A Giovino; M W Schooley; B P Zhu; J H Chrismon; S L Tomar; J P Peddicord; R K Merritt; C G Husten; M P Eriksen
Journal:  MMWR CDC Surveill Summ       Date:  1994-11-18

7.  The US tobacco control community's view of the future of tobacco harm reduction.

Authors:  K E Warner; E G Martin
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

8.  Tobacco harm reduction: what do the experts think?

Authors:  E G Martin; K E Warner; P M Lantz
Journal:  Tob Control       Date:  2004-06       Impact factor: 7.552

9.  Community tobacco control leaders' perceptions of harm reduction.

Authors:  A M Joseph; D Hennrikus; M J Thoele; R Krueger; D Hatsukami
Journal:  Tob Control       Date:  2004-06       Impact factor: 7.552

Review 10.  Cancer fatalism: the state of the science.

Authors:  Barbara D Powe; Ramona Finnie
Journal:  Cancer Nurs       Date:  2003-12       Impact factor: 2.592

View more
  16 in total

1.  Food and Drug Administration tobacco regulation and product judgments.

Authors:  Annette R Kaufman; Lila J Finney Rutten; Mark Parascandola; Kelly D Blake; Erik M Augustson
Journal:  Am J Prev Med       Date:  2015-02-25       Impact factor: 5.043

2.  Using eye-tracking to examine how embedding risk corrective statements improves cigarette risk beliefs: Implications for tobacco regulatory policy.

Authors:  Kirsten Lochbuehler; Kathy Z Tang; Valentina Souprountchouk; Dana Campetti; Joseph N Cappella; Lynn T Kozlowski; Andrew A Strasser
Journal:  Drug Alcohol Depend       Date:  2016-05-02       Impact factor: 4.492

3.  Adult interest in using a hypothetical modified risk tobacco product: findings from wave 1 of the Population Assessment of Tobacco and Health Study (2013-14).

Authors:  Jennifer L Pearson; Amanda L Johnson; Sarah E Johnson; Cassandra A Stanton; Andrea C Villanti; Raymond S Niaura; Allison M Glasser; Baoguang Wang; David B Abrams; K Michael Cummings; Andrew Hyland
Journal:  Addiction       Date:  2017-09-06       Impact factor: 6.526

4.  Cultural values associated with substance use among Hispanic emerging adults in Southern California.

Authors:  Patricia Escobedo; Jon-Patrick Allem; Lourdes Baezconde-Garbanati; Jennifer B Unger
Journal:  Addict Behav       Date:  2017-07-14       Impact factor: 3.913

5.  Reduced nicotine content cigarette advertising: How false beliefs and subjective ratings affect smoking behavior.

Authors:  Melissa Mercincavage; Megan L Saddleson; Emily Gup; Angela Halstead; Darren Mays; Andrew A Strasser
Journal:  Drug Alcohol Depend       Date:  2017-02-03       Impact factor: 4.492

6.  Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.

Authors:  Irina Stepanov; Lois Biener; Katrina Yershova; Amy L Nyman; Robin Bliss; Mark Parascandola; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2014-03-06       Impact factor: 4.244

7.  Monitoring harm perceptions of smokeless tobacco products among U.S. adults: Health Information National Trends Survey 2012, 2014, 2015.

Authors:  Shari P Feirman; Elisabeth A Donaldson; Mark Parascandola; Kimberly Snyder; Cindy Tworek
Journal:  Addict Behav       Date:  2017-09-09       Impact factor: 3.913

Review 8.  Inflammatory response of lung macrophages and epithelial cells to tobacco smoke: a literature review of ex vivo investigations.

Authors:  Lauren A Smith; Geraldine M Paszkiewicz; Alan D Hutson; John L Pauly
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

9.  US Adult Interest in Less Harmful and Less Addictive Hypothetical Modified Risk Tobacco Products.

Authors:  Erin Keely O'Brien; Alexander Persoskie; Mark Parascandola; Allison C Hoffman
Journal:  Nicotine Tob Res       Date:  2018-09-25       Impact factor: 4.244

10.  Surveillance indicators for potential reduced exposure products (PREPs): developing survey items to measure awareness.

Authors:  Karen Bogen; Lois Biener; Catherine A Garrett; Jane Allen; K Michael Cummings; Anne Hartman; Stephen Marcus; Ann McNeill; Richard J O'Connor; Mark Parascandola; Linda Pederson
Journal:  Harm Reduct J       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.